Patient related outcomes in a real life prospective follow up study: Allergen immunotherapy increase quality of life and reduce sick days.

ABSTRACT:

Background

One fourth of the adult population in Europe suffer from respiratory allergy. Subcutaneous-allergen-specific-immunotherapy (SCIT) has long-term disease modifying effect on disease specific Health-Related Quality of Life (HRQoL). The purpose of this study was to assess the effect of SCIT on alternative disease outcomes in patients with grass-pollen and/or house dust mite induced allergic rhino-conjunctivitis and/or an asthma diagnosis. Focus was on expressing outcomes in terms of generic quality of life (Quality-Adjusted-Life-Years (QALY)) and reductions in sick days.

Methods

The study was a multi-centre study with prospective follow-up. 248 patients were initiated on SCIT. The disease specific Rhino-conjunctivitis Quality of Life Questionnaire (RQLQ) and two gener

SUBMITTER: Petersen KD 

PROVIDER: S-EPMC3846409 | biostudies-literature | 2013 Sep

REPOSITORIES: biostudies-literature